USAN Watch - March 2012
| USAN | Research Code | Structure | Drug Class | Therapeutic class | Target |
| abediterol, abediterol napadisylate | LAS-100977 |  | synthetic small molecule | therapeutic |
beta 2 receptor
|
| gemcitabine elaidate | CP-4126 |  | natural product derived small molecule prodrug | therapeutic | DNA replication |
| golvatinib, golvatinib tartrate | E-7050 |  | synthetic small molecule | therapeutic | MET, VEGFR2 |
| naldemedine tosylate |  | natural product derived small molecule | therapeutic | opioid receptors | |
| ocaratuzumab | AME-133v, LY-2469298 | mAb | therapeutic | CD20 | |
| quisinostat hydrochloride | JNJ-26481585, JNJ-26481585-AAC |  | synthetic small molecule | therapeutic | HDACs |
| setipiprant | ACT-129968 |  | synthetic small molecule | therapeutic | CRTH2 |
| tildipirosin | Zuprevo |  | natural product derived small molecule | therapeutic | 50S ribosome |
| tirasemtiv | CK-2017357 |  | synthetic small molecule | therapeutic | troponin activator |
| zicronapine, zicronapine succinate | Lu-31-130 |  | synthetic small molecule | therapeutic | D1, 5HT2A receptors |
All are human, with the exception of Tildipirosin, which is intended for bovine use.